Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis.
about
CX3CR1 is a modifying gene of survival and progression in amyotrophic lateral sclerosisMajor Histocompatibility Complex I Expression by Motor Neurons and Its Implication in Amyotrophic Lateral SclerosisCentral Nervous System-Peripheral Immune System Dialogue in Neurological Disorders: Possible Application of Neuroimmunology in UrologyRedox regulation of T-cell function: from molecular mechanisms to significance in human health and diseaseThe role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?Microglia centered pathogenesis in ALS: insights in cell interconnectivityReduced β-amyloid pathology in an APP transgenic mouse model of Alzheimer's disease lacking functional B and T cellsFriend or foe: the dichotomous impact of T cells on neuro-de/re-generation during agingMicroglia induce motor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis.The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosisBlood biomarkers for amyotrophic lateral sclerosis: myth or reality?The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injuryTransformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS.A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse modelEarly-stage treatment with Withaferin A reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis.Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1.Microglial and macrophage polarization—new prospects for brain repairProtective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice.Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosisImmune aging, dysmetabolism, and inflammation in neurological diseases.Humoral factors in ALS patients during disease progression.Concurrent multiple sclerosis and amyotrophic lateral sclerosis: where inflammation and neurodegeneration meet?A data-driven approach links microglia to pathology and prognosis in amyotrophic lateral sclerosisA Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative DisordersExacerbation of experimental autoimmune encephalomyelitis in the absence of breast regression protein 39/chitinase 3-like 1.CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease.Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease.Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling.Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survivalUse of biomarkers in ALS drug development and clinical trialsGenetic variability in the rat Aplec C-type lectin gene cluster regulates lymphocyte trafficking and motor neuron survival after traumatic nerve root injuryAge-Associated Resident Memory CD8 T Cells in the Central Nervous System Are Primed To Potentiate Inflammation after Ischemic Brain Injury.Neurovascular unit in chronic pain.Tocilizumab infusion therapy normalizes inflammation in sporadic ALS patients.Adoptive regulatory T-cell therapy protects against cerebral ischemia.Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis.Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis.
P2860
Q21132045-46474028-2762-40CB-B951-26F03F55309BQ26744608-719D60AF-C041-4DF5-A9E5-A16926D972D2Q26745684-F01BCDD5-4F23-4FD9-9D79-33C167ADA883Q26824042-BA9131E9-8397-4382-8778-224FB00CA25CQ26861263-7776A00A-1B7D-4D48-ADB3-2FDE095958E9Q27009559-904D47EE-F657-4F9A-9706-BE8F37B3B5A8Q27317159-F2A1B219-10A4-499D-BC24-AB30C5038722Q28077869-6384EF77-E1B5-4354-B6AF-61A236FFC9EEQ30575638-5E7CD2EA-98EF-46B5-895B-1E2FFEA45858Q33633778-CB8A80F3-8367-4B00-88EE-D6A0E11FC906Q33767845-DBCF3D45-D97F-4992-B445-6B0636D5D8AAQ33907002-3458BA94-8743-4BD5-BA78-E71B2B2715ACQ34019767-6DB995CE-8D2D-415A-800B-44940F4636F5Q34746889-2F197F76-8198-4473-8AA3-2AD5F056040DQ35064952-6538DEC6-650E-4D3C-83E3-72DB13A34B14Q35068792-494C259E-6791-414F-8361-A5E462177F87Q35176619-FD0C316F-4499-4DD7-8F6A-6CBAFDA5B978Q35365484-01A7F4A2-3E72-4AA3-89AC-5714D7DC4A23Q35394922-8F69EE08-27DE-4C5E-832A-ABE06173D666Q35501874-8A505C1E-0A97-4A16-A81C-B9F5A219CB12Q35591425-C24863C7-B034-4189-867D-51C3AEAA863FQ35665302-DBBBFE73-A768-4923-8BCD-999552B25049Q35677347-EE3F198C-C3F0-4ED5-BC22-641800B802D6Q35806256-465EEFE5-1D5D-4900-8352-80202EE5D863Q35842339-83CDBF6E-FDBE-4576-B516-1BA382A7CB66Q36311348-7E7F46FC-2723-4810-9270-4204E0C2A495Q36326816-864A75D8-8167-469A-B524-D0C5445BF8BFQ36346806-C56D1DF7-0A33-4102-AD80-A5C5A890B59DQ36449229-1A1151DB-B57F-4A31-BED9-967DF57940C5Q36474039-5C84C3B7-DD6F-49F3-A52F-D28C5CDE2E73Q36576467-5DB9238E-4FD9-4B14-B142-5371F0A12F8EQ36602163-D1F4C95F-815E-45C4-817A-18249731B799Q36733981-AFD90773-D38F-4721-B72B-1407C460A4BBQ36866992-80625846-9B41-400E-83DE-12A19A419C60Q36905550-A525F06A-9C57-4E3E-BD82-400708356432Q36942721-E137A0AD-5052-4724-B22F-D585D06B1D7AQ36987643-DD9C0D5B-4E6B-4DA8-86E2-1F3B7A8D0DD4Q37107049-2C3F7BB0-50FD-4781-A7C0-96300AC651EEQ37189268-4AC42818-8650-4216-81ED-B90197AC757AQ37322677-2108F3E3-9988-485A-9A6C-07F325DA06EC
P2860
Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Endogenous regulatory T lympho ...... amyotrophic lateral sclerosis.
@ast
Endogenous regulatory T lympho ...... amyotrophic lateral sclerosis.
@en
Endogenous regulatory T lympho ...... amyotrophic lateral sclerosis.
@nl
type
label
Endogenous regulatory T lympho ...... amyotrophic lateral sclerosis.
@ast
Endogenous regulatory T lympho ...... amyotrophic lateral sclerosis.
@en
Endogenous regulatory T lympho ...... amyotrophic lateral sclerosis.
@nl
prefLabel
Endogenous regulatory T lympho ...... amyotrophic lateral sclerosis.
@ast
Endogenous regulatory T lympho ...... amyotrophic lateral sclerosis.
@en
Endogenous regulatory T lympho ...... amyotrophic lateral sclerosis.
@nl
P2093
P2860
P356
P1433
P1476
Endogenous regulatory T lympho ...... amyotrophic lateral sclerosis.
@en
P2093
Ailing Huang
David R Beers
Jenny S Henkel
Jinghong Wang
Shixiang Wen
Weihua Zhao
P2860
P304
P356
10.1093/BRAIN/AWR074
P407
P577
2011-05-01T00:00:00Z